Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Quantifying Hepatic Mitochondrial Fluxes in Humans — Stella

Home/Non-Alcoholic Fatty Liver Disease/Quantifying Hepatic Mitochondrial Fluxes in Humans

View on ClinicalTrials.gov

Recruiting

Back to Non-Alcoholic Fatty Liver Disease trials

Quantifying Hepatic Mitochondrial Fluxes in Humans

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

United States

Texas Diabetes Institute - University Health System, San Antonio, Texas

University of Texas Health Science Center at San Antonio, San Antonio, Texas

Key details

Phase

Post-approval study

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrollment target

~60 participants

Started

November 2022

Primary completion

March 2027

Age range

18 Years – 80 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.